{
  "schemaVersion": 2,
  "eyebrow": "Nephrology / Critical Care",
  "title": "Hyponatremia Overcorrection Management",
  "summary": "Prevent osmotic demyelination by identifying patients at greatest risk, tracking sodium trajectory and urine output during active correction, arresting water diuresis with desmopressin, and promptly relowering sodium with electrolyte-free water when correction limits are exceeded.",
  "seoDescription": "Point-of-care management of hyponatremia overcorrection: correction limits, high-risk features, desmopressin, D5W relowering, and monitoring.",
  "clinicalQuestion": "How should clinicians prevent, recognize, and reverse overly rapid sodium correction in severe hyponatremia?",
  "specialty": "Nephrology and Critical Care Medicine",
  "audience": "U.S. physicians and medical trainees",
  "tags": [
    "hyponatremia overcorrection",
    "osmotic demyelination syndrome",
    "desmopressin clamp",
    "D5W relowering",
    "sodium correction limits",
    "hypertonic saline"
  ],
  "keyTakeaways": [
    "For chronic or unknown-duration hyponatremia with sodium 120 mEq/L or less, use a 24-hour correction limit of 10-12 mEq/L and a 48-hour limit of 18 mEq/L in usual-risk patients; use no more than 8 mEq/L in any 24 hours for patients at high risk for osmotic demyelination. [23]",
    "Treat sodium 105 mEq/L or less, alcohol use disorder, hypokalemia, malnutrition, and advanced liver disease as major osmotic demyelination risk factors and aim for a 4-6 mEq/L daily correction goal in this group. [13][20][23]",
    "A sudden large volume of dilute urine during therapy signals emerging aquaresis and impending overcorrection; intensify sodium and urine monitoring and use desmopressin to arrest free-water loss. [16][19][22]",
    "In chronic or unknown-duration severe hyponatremia with excessive correction, particularly with osmotic demyelination risk factors, consider therapeutic relowering with electrolyte-free water with or without desmopressin to bring sodium just below the applicable correction limit. [13][14][18]"
  ],
  "sections": [
    {
      "id": "act-when-the-sodium-trajectory-is-unsafe",
      "eyebrow": "Immediate response",
      "heading": "When to declare overcorrection and intervene",
      "intro": "Base intervention on the cumulative sodium rise, duration, and osmotic demyelination risk.",
      "paragraphs": [
        "Treat hyponatremia as chronic when duration exceeds 48 hours and as high-consequence when duration is unknown and serum sodium is below 120 mEq/L. For usual-risk chronic hyponatremia, the U.S./Irish expert-panel limits are 10-12 mEq/L in any 24 hours and 18 mEq/L in 48 hours, with a minimum intended correction of 4-8 mEq/L daily. For high-risk patients, do not exceed 8 mEq/L in any 24 hours; target 4-6 mEq/L daily rather than pursuing normalization. [20][23]",
        "Declare the trajectory unsafe before the formal limit is crossed when a patient has already gained about 6 mEq/L in 24 hours and develops a brisk water diuresis, because further unopposed urinary free-water loss can rapidly breach the limit. In an observational cohort, a reactive desmopressin strategy was used when the 24-hour sodium goal of 6 mEq/L had been reached or urine output exceeded 1 mL/kg/hour. [16]",
        "Risk is concentrated in chronic or unknown-duration severe hyponatremia, especially sodium 105 mEq/L or less, alcohol use disorder, hypokalemia, malnutrition, or advanced liver disease. These features should lower the action threshold: once correction is exceeding or appears likely to exceed 8 mEq/L over 24 hours, prevent further rise and consider relowering rather than accepting a higher cumulative increment. [13][20][23]"
      ],
      "bullets": [
        "Record a baseline sodium and calculate every subsequent change from that value; assess both the current 24-hour and cumulative 48-hour increments. [13][23]",
        "Insert or maintain accurate urine-output measurement during active correction; abrupt high output and visibly dilute urine are actionable warning signs of water diuresis. [16][19][22]",
        "Do not wait for neurologic manifestations of osmotic demyelination before relowering; symptoms commonly occur days after the excessive correction. [18]"
      ],
      "subsections": [],
      "table": {
        "caption": "Correction limits and response thresholds for chronic or unknown-duration hyponatremia. [13][20][23]",
        "columns": [
          "Risk stratum",
          "Features",
          "Daily correction goal",
          "Upper correction limit",
          "Action if trajectory is unsafe"
        ],
        "rows": [
          [
            "Usual risk",
            "Chronic or unknown duration; no major osmotic demyelination risk factor identified. [23]",
            "4-8 mEq/L. [23]",
            "10-12 mEq/L in any 24 hours; 18 mEq/L in 48 hours. [23]",
            "Stop the source of ongoing correction, detect water diuresis, and use desmopressin and/or electrolyte-free water when correction exceeds limits or is likely to do so. [13][14][16]"
          ],
          [
            "High risk",
            "Sodium 105 mEq/L or less, alcohol use disorder, hypokalemia, malnutrition, or advanced liver disease. [13][20][23]",
            "4-6 mEq/L. [20][23]",
            "8 mEq/L in any 24 hours. [13][23]",
            "Promptly arrest further water loss and consider relowering sodium just below the correction limit. [13][14]"
          ]
        ]
      }
    },
    {
      "id": "stop-the-mechanism-of-overcorrection",
      "eyebrow": "Bedside recognition",
      "heading": "Identify water diuresis before it causes a large sodium rise",
      "intro": "Most dangerous overshoots occur when renal diluting capacity suddenly returns.",
      "paragraphs": [
        "Excessive correction frequently follows restoration of the kidney's ability to excrete dilute urine after treatment of the underlying cause. Track hourly urine output, urine appearance, serum sodium, and urine osmolality during active therapy; dilute high-volume urine is the bedside signature that electrolyte-free water is being lost and sodium may rise abruptly. [13][19][22]",
        "Patients with low-solute intake or beer potomania are particularly vulnerable to brisk aquaresis after isotonic or hypertonic saline. A history of heavy alcohol intake with poor nutritional intake and low urine osmolality supports this branch; avoid assuming that saline will produce a controlled increment, because it can trigger rapid free-water diuresis. [18]",
        "Correction may also accelerate after treatment-related volume restoration, intentional diuresis in hypervolemic states, or removal of a reversible antidiuretic stimulus. The management priority is not to continue chasing a sodium target with saline once auto-diuresis begins; instead, measure the changing sodium trajectory frequently and halt ongoing free-water losses. [13][19]"
      ],
      "bullets": [
        "During active correction, measure serum sodium every 4-6 hours until stable; increase to every 2 hours when managing active overcorrection or using desmopressin to control the trajectory. [19][22]",
        "Obtain urine osmolality alongside serum sodium when rapid correction is suspected; falling urine concentration with rising urine output supports water diuresis as the driver. [19]",
        "Correct hypokalemia while recognizing that hypokalemia itself identifies a patient at increased osmotic demyelination risk and warrants the stricter sodium ceiling. [13][20][23]"
      ],
      "subsections": [],
      "table": {
        "caption": "Signals that should trigger escalation from observation to active prevention of further sodium rise. [16][19][22]",
        "columns": [
          "Finding during correction",
          "Interpretation",
          "Immediate next action"
        ],
        "rows": [
          [
            "Urine output greater than 1 mL/kg/hour after sodium begins to rise",
            "Possible emerging water diuresis and likely acceleration of correction. [16]",
            "Recalculate the 24-hour increment, obtain serum sodium and urine osmolality, and consider reactive desmopressin. [16][19]"
          ],
          [
            "Large-volume visibly dilute urine",
            "Urinary electrolyte-free water loss may cause rapid sodium increase. [19]",
            "Increase sodium and urine monitoring to every 2 hours; arrest free-water loss with desmopressin if correction is accelerating. [19]"
          ],
          [
            "Rise already near 6 mEq/L in 24 hours in a high-risk patient",
            "Only a small remaining margin exists before the 8 mEq/L/24-hour ceiling. [16][23]",
            "Do not continue unopposed correction; use a reactive strategy to prevent limit breach. [16]"
          ],
          [
            "Correction exceeds the applicable limit",
            "Overcorrection requiring active mitigation, particularly in chronic or unknown-duration sodium below 120 mEq/L. [13][23]",
            "Consider therapeutic relowering with electrolyte-free water with or without desmopressin. [13][14][18]"
          ]
        ]
      }
    },
    {
      "id": "desmopressin-and-relowering",
      "eyebrow": "Rescue treatment",
      "heading": "Use desmopressin and D5W to stop or reverse overcorrection",
      "intro": "The objective is controlled sodium trajectory, not immediate normonatremia.",
      "paragraphs": [
        "Use desmopressin reactively when sodium is rising too quickly or when high-volume water diuresis makes a limit breach likely. Desmopressin slows the rate of sodium change by preventing continued free-water loss; one critical-care approach uses 2 mcg intravenously every 8 hours as needed, reassessing urine concentration after 1-2 hours and measuring serum sodium and urine osmolality every 2 hours. [16][19]",
        "For severe hyponatremia with sodium below 120 mEq/L of chronic or unknown duration that has corrected excessively, especially when osmotic demyelination risk factors are present, therapeutic relowering should be considered with the goal of returning sodium to just below the applicable correction limit. Electrolyte-free water, usually D5W, with or without desmopressin is used to replace or retain free water and reverse the excessive increment. [13][14][18]",
        "In beer potomania, when sodium rises faster than 10 mEq/L in 24 hours or 18 mEq/L in 48 hours, D5W may be infused at a rate matching urine output; add desmopressin if needed to stop ongoing free-water losses. Because high-risk patients require a more conservative 8 mEq/L per 24-hour ceiling, intervene earlier in those with alcohol use disorder, malnutrition, hypokalemia, advanced liver disease, or sodium 105 mEq/L or less. [18][23]"
      ],
      "bullets": [
        "Give desmopressin only with close monitoring of serum sodium and fluid balance; continued hypotonic fluid without reassessment can reinduce or worsen hyponatremia. [19]",
        "Once desmopressin has concentrated the urine and sodium is back within a safe trajectory, reassess the underlying hyponatremia treatment rather than automatically continuing saline. [19]",
        "If sodium correction has substantially exceeded the limit in a high-risk patient, obtain urgent nephrology and critical-care input while initiating monitored relowering; the recommendation for relowering is based on expert opinion and low-quality evidence, but the neurologic consequence being prevented can be catastrophic. [13]"
      ],
      "subsections": [
        {
          "heading": "Avoid a second iatrogenic error",
          "paragraphs": [
            "Do not use tolvaptan to rescue overcorrection. Tolvaptan can itself produce overly rapid sodium correction and must be initiated or reinitiated in a hospital with close sodium monitoring. It is contraindicated in hypovolemic hyponatremia, inability to sense or respond to thirst, anuria, and concomitant strong CYP3A inhibitors. [3][6]"
          ],
          "bullets": [
            "If a patient recently received tolvaptan, recognize an added risk of aquaresis-driven sodium rise and maintain close inpatient sodium monitoring. [3][6]",
            "Do not respond to excessive correction by simply withholding further therapy if brisk aquaresis persists; ongoing urine water loss can continue raising sodium after all saline has stopped. [13][19]"
          ]
        }
      ],
      "table": {
        "caption": "Active management of an unsafe sodium trajectory. [13][16][18][19]",
        "columns": [
          "Clinical scenario",
          "Primary intervention",
          "Monitoring endpoint"
        ],
        "rows": [
          [
            "Rapidly rising sodium with high-volume dilute urine but no limit breach yet",
            "Reactive desmopressin; a cited approach is 2 mcg IV every 8 hours as needed. [16][19]",
            "Urine becomes more concentrated within 1-2 hours; serum sodium and urine osmolality every 2 hours. [19]"
          ],
          [
            "Excessive correction in chronic or unknown-duration severe hyponatremia",
            "D5W/electrolyte-free water with or without desmopressin to relower sodium. [13][14][18]",
            "Bring sodium just below the applicable correction limit, then prevent recurrent rise. [13]"
          ],
          [
            "Beer potomania with sodium rise faster than 10 mEq/L/24 hours or 18 mEq/L/48 hours",
            "Infuse D5W to match urine output; add desmopressin if needed. [18]",
            "Match replacement to ongoing urine losses and follow sodium closely. [18]"
          ]
        ]
      }
    },
    {
      "id": "monitor-for-delayed-neurologic-injury",
      "eyebrow": "Post-event surveillance",
      "heading": "Continue surveillance after sodium is back within limits",
      "intro": "Relowering addresses risk; it does not exclude delayed osmotic demyelination.",
      "paragraphs": [
        "Osmotic demyelination can cause dysarthria, mutism, dysphagia, lethargy, affective changes, spastic quadriparesis, seizures, coma, and death after overly rapid correction. Continue serial neurologic examinations after an overcorrection event, particularly in patients with alcohol use disorder, malnutrition, hypokalemia, advanced liver disease, or very low presenting sodium. [3][6][13]",
        "The syndrome is rare overall but risk rises as initial sodium declines. A systematic review reported an osmotic demyelination incidence of 0.31% among patients with initial sodium below 120 mmol/L, while studies enrolling patients with sodium below 116 mmol/L reported 2.9%; rapid correction above 8 mmol/L in 24 hours was associated with greater risk. [21]",
        "Document the baseline sodium, all sodium values and times, total 24- and 48-hour increments, urine-output pattern, desmopressin administration, D5W administration, and the revised correction target. This record allows handoffs to preserve the correction ceiling across shifts and prevents inadvertent re-escalation of saline, diuretics, or aquaretic therapy. [13][19][22]"
      ],
      "bullets": [
        "Maintain serum sodium checks every 4-6 hours with active treatment until sodium stabilizes; use every-2-hour measurements during active rescue. [19][22]",
        "Escalate immediately for new dysarthria, dysphagia, mutism, weakness, seizures, or declining consciousness after a correction event. These are recognized manifestations of osmotic demyelination. [3][6]",
        "Do not treat the absence of immediate neurologic findings as reassurance after an excessive correction; preventive relowering is recommended before manifestations appear in appropriate high-risk patients. [13][18]"
      ],
      "subsections": [],
      "table": {
        "caption": "Practical monitoring after excessive correction. [3][13][19][22]",
        "columns": [
          "Interval",
          "Measure",
          "Decision changed by result"
        ],
        "rows": [
          [
            "Every 2 hours during active rescue",
            "Serum sodium, urine output, and urine osmolality. [19]",
            "Titrate measures that arrest or replace free-water loss and avoid further sodium rise. [19]"
          ],
          [
            "Every 4-6 hours until stable during active correction",
            "Serum sodium and urine output. [22]",
            "Confirm that the cumulative 24- and 48-hour correction remains within the selected ceiling. [22][23]"
          ],
          [
            "Ongoing after the event",
            "Focused neurologic examination for dysarthria, dysphagia, mutism, weakness, seizures, or altered consciousness. [3][6]",
            "Prompt escalation for possible osmotic demyelination syndrome. [3][6]"
          ]
        ]
      }
    },
    {
      "id": "apply-the-plan-to-common-high-risk-settings",
      "eyebrow": "Clinical application",
      "heading": "Choose a conservative strategy in patients most likely to overshoot",
      "intro": "Risk phenotype should determine the correction ceiling before therapy begins.",
      "paragraphs": [
        "For sodium 105 mEq/L or less or chronic severe hyponatremia with alcohol use disorder, malnutrition, hypokalemia, or advanced liver disease, select the 8 mEq/L-per-24-hour maximum from the outset and aim for only 4-6 mEq/L daily. A correction of 8-12 mEq/L during the first day may be unnecessary even in usual-risk patients, and high-risk patients have the least margin for spontaneous aquaresis. [20][23]",
        "For low-solute hyponatremia, anticipate that restoring solute or giving saline may permit brisk water excretion. Low urine osmolality in the setting of heavy alcohol use and poor nutritional intake supports beer potomania; monitor intensively rather than relying on fluid restriction or crystalloid alone to produce a predictable sodium response. [18]",
        "For patients treated with hypertonic saline for symptomatic hyponatremia, guidelines support rapid intermittent bolus therapy in acute symptomatic presentations and chronic hyponatremia with severe symptoms, but overcorrection remains a measurable adverse laboratory outcome requiring surveillance. Once immediate symptoms improve, shift from emergency correction to the conservative cumulative limits above. [9][12][22]"
      ],
      "bullets": [
        "Treat the correction limit as a safety ceiling, not a desired endpoint. [23]",
        "Reassess each new sodium value against both the daily goal and the maximum allowed increment; a favorable neurologic response does not justify continued uncontrolled rise. [22][23]",
        "Use a lower threshold for desmopressin and D5W rescue when the duration is unknown, because unknown duration is managed as potentially chronic for osmotic demyelination risk. [13]"
      ],
      "subsections": [],
      "table": {
        "caption": "High-risk phenotypes and the preventive implication. [13][18][20][23]",
        "columns": [
          "Phenotype",
          "Why correction is hazardous",
          "Preventive management implication"
        ],
        "rows": [
          [
            "Sodium 105 mEq/L or less",
            "Major osmotic demyelination risk factor. [13][20][23]",
            "Target 4-6 mEq/L/day and do not exceed 8 mEq/L in any 24 hours. [20][23]"
          ],
          [
            "Alcohol use disorder or malnutrition",
            "Major osmotic demyelination risk factors; may coexist with low-solute intake. [13][20][23]",
            "Use the high-risk ceiling and monitor closely for aquaresis after solute or saline. [18][23]"
          ],
          [
            "Hypokalemia",
            "Major osmotic demyelination risk factor. [13][20][23]",
            "Correct potassium while maintaining the high-risk sodium ceiling and close sodium surveillance. [20][23]"
          ],
          [
            "Advanced liver disease",
            "Major osmotic demyelination risk factor. [13][20][23]",
            "Use the high-risk ceiling and favor early intervention for an unsafe trajectory. [13][23]"
          ],
          [
            "Beer potomania",
            "Saline can trigger brisk free-water diuresis and rapid correction. [18]",
            "Track urine output and sodium closely; use D5W matched to urine output and desmopressin if correction becomes excessive. [18]"
          ]
        ]
      }
    }
  ],
  "faq": [],
  "references": [
    {
      "number": 1,
      "title": "These highlights do not include all the information needed to use ...",
      "detail": "dailymed.nlm.nih.gov",
      "url": "https://dailymed.nlm.nih.gov/dailymed/fda/fdaDrugXsl.cfm?setid=e5bbb3e1-ab50-4ec7-a2b4-ce4091712e23&type=display",
      "authors": "dailymed.nlm.nih.gov",
      "host": "dailymed.nlm.nih.gov"
    },
    {
      "number": 2,
      "title": "[PDF] center for drug evaluation and - accessdata.fda.gov",
      "detail": "www.accessdata.fda.gov",
      "url": "https://www.accessdata.fda.gov/drugsatfda_docs/nda/2009/022275s000_Lbl.pdf",
      "authors": "www.accessdata.fda.gov",
      "host": "www.accessdata.fda.gov"
    },
    {
      "number": 3,
      "title": "[PDF] SAMSCA - DailyMed",
      "detail": "dailymed.nlm.nih.gov",
      "url": "https://dailymed.nlm.nih.gov/dailymed/getFile.cfm?setid=5526617c-c7b9-4556-886d-729bbabbc566&type=pdf",
      "authors": "dailymed.nlm.nih.gov",
      "host": "dailymed.nlm.nih.gov"
    },
    {
      "number": 4,
      "title": "[PDF] Page 1 of 27 This label may not be the latest approved by FDA. For ...",
      "detail": "www.accessdata.fda.gov",
      "url": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2009/022275lbl.pdf",
      "authors": "www.accessdata.fda.gov",
      "host": "www.accessdata.fda.gov"
    },
    {
      "number": 5,
      "title": "[PDF] 3080478 This label may not be the latest approved by FDA. For ...",
      "detail": "www.accessdata.fda.gov",
      "url": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/022275s005lbl.pdf",
      "authors": "www.accessdata.fda.gov",
      "host": "www.accessdata.fda.gov"
    },
    {
      "number": 6,
      "title": "[PDF] tolvaptan tablet - DailyMed",
      "detail": "dailymed.nlm.nih.gov",
      "url": "https://dailymed.nlm.nih.gov/dailymed/getFile.cfm?setid=c075d517-f4c8-469a-9f51-416ef61c6a83&type=pdf",
      "authors": "dailymed.nlm.nih.gov",
      "host": "dailymed.nlm.nih.gov"
    },
    {
      "number": 7,
      "title": "[PDF] POTASSIUM CHLORIDE IN DEXTROSE - DailyMed",
      "detail": "dailymed.nlm.nih.gov",
      "url": "https://dailymed.nlm.nih.gov/dailymed/getFile.cfm?setid=e5bbb3e1-ab50-4ec7-a2b4-ce4091712e23&type=pdf",
      "authors": "dailymed.nlm.nih.gov",
      "host": "dailymed.nlm.nih.gov"
    },
    {
      "number": 8,
      "title": "Correction Rates and Clinical Outcomes in Hospitalized Adults With ...",
      "detail": "jamanetwork.com",
      "url": "https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/2826087",
      "authors": "jamanetwork.com",
      "host": "jamanetwork.com"
    },
    {
      "number": 9,
      "title": "Risk of Overcorrection in Rapid Intermittent Bolus vs Slow ...",
      "detail": "jamanetwork.com",
      "url": "https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/2772353",
      "authors": "jamanetwork.com",
      "host": "jamanetwork.com"
    },
    {
      "number": 10,
      "title": "Diagnosis and Management of Hyponatremia: A Review",
      "detail": "jamanetwork.com",
      "url": "https://jamanetwork.com/journals/jama/fullarticle/2794358",
      "authors": "jamanetwork.com",
      "host": "jamanetwork.com"
    },
    {
      "number": 11,
      "title": "Hyponatremia | Annals of Internal Medicine - ACP Journals",
      "detail": "www.acpjournals.org",
      "url": "https://www.acpjournals.org/doi/10.7326/AITC201508040",
      "authors": "www.acpjournals.org",
      "host": "www.acpjournals.org"
    },
    {
      "number": 12,
      "title": "In hyponatremia, rapid intermittent bolus vs. slow continuous ...",
      "detail": "www.acpjournals.org",
      "url": "https://www.acpjournals.org/doi/10.7326/ACPJ202103160-033",
      "authors": "www.acpjournals.org",
      "host": "www.acpjournals.org"
    },
    {
      "number": 13,
      "title": "Therapeutic Relowering of Plasma Sodium after... : Clinical Journal of the American Society of Nephrology",
      "detail": "journals.lww.com",
      "url": "https://journals.lww.com/cjasn/fulltext/10.2215/cjn.04880419~therapeutic-relowering-of-plasma-sodium-after-overly-rapid",
      "authors": "journals.lww.com",
      "host": "journals.lww.com"
    },
    {
      "number": 14,
      "title": "Risk Factors, Complication and Measures to Prevent or Reverse Catastrophic Sodium Overcorrection in Chronic Hyponatremia - ScienceDirect",
      "detail": "www.sciencedirect.com",
      "url": "https://www.sciencedirect.com/science/article/pii/S0002962915301245",
      "authors": "www.sciencedirect.com",
      "host": "www.sciencedirect.com"
    },
    {
      "number": 15,
      "title": "Use of the Desmopressin Clamp in Hyponatremia : Kidney360",
      "detail": "journals.lww.com",
      "url": "https://journals.lww.com/kidney360/fulltext/2025/09000/use_of_the_desmopressin_clamp_in_hyponatremia_.2.aspx",
      "authors": "journals.lww.com",
      "host": "journals.lww.com"
    },
    {
      "number": 16,
      "title": "Outcomes in Severe Hyponatremia Treated With and Without Desmopressin - ScienceDirect",
      "detail": "www.sciencedirect.com",
      "url": "https://www.sciencedirect.com/science/article/abs/pii/S0002934317310434",
      "authors": "www.sciencedirect.com",
      "host": "www.sciencedirect.com"
    },
    {
      "number": 17,
      "title": "Osmotic Demyelination Syndrome - ScienceDirect",
      "detail": "www.sciencedirect.com",
      "url": "https://www.sciencedirect.com/science/article/pii/S0002962915315810",
      "authors": "www.sciencedirect.com",
      "host": "www.sciencedirect.com"
    },
    {
      "number": 18,
      "title": "Potomania - an overview | ScienceDirect Topics",
      "detail": "www.sciencedirect.com",
      "url": "https://www.sciencedirect.com/topics/medicine-and-dentistry/potomania",
      "authors": "www.sciencedirect.com",
      "host": "www.sciencedirect.com"
    },
    {
      "number": 19,
      "title": "The Resuscitationist’s Approach to Severe Hyponatremia | Critical Care Medicine Section",
      "detail": "www.acep.org",
      "url": "https://www.acep.org/criticalcare/newsroom/newsroom-articles/september2022/the-resuscitationists-approach-to-severe-hyponatremia",
      "authors": "www.acep.org",
      "host": "www.acep.org"
    },
    {
      "number": 20,
      "title": "Effects of Correction Rate for Severe Hyponatremia in the Intensive Care Unit on Patient Outcomes",
      "detail": "pmc.ncbi.nlm.nih.gov",
      "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC10524223",
      "authors": "pmc.ncbi.nlm.nih.gov",
      "host": "pmc.ncbi.nlm.nih.gov"
    },
    {
      "number": 21,
      "title": "Hyponatremia Correction and Osmotic Demyelination Syndrome Risk: A Systematic Review and Meta-Analysis",
      "detail": "pmc.ncbi.nlm.nih.gov",
      "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC11833618",
      "authors": "pmc.ncbi.nlm.nih.gov",
      "host": "pmc.ncbi.nlm.nih.gov"
    },
    {
      "number": 22,
      "title": "Difficulties in the diagnosis and management of hyponatremia - PMC",
      "detail": "pmc.ncbi.nlm.nih.gov",
      "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC5111484",
      "authors": "pmc.ncbi.nlm.nih.gov",
      "host": "pmc.ncbi.nlm.nih.gov"
    },
    {
      "number": 23,
      "title": "Treatment Guidelines for Hyponatremia: Stay the Course - PMC",
      "detail": "pmc.ncbi.nlm.nih.gov",
      "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC10843202",
      "authors": "pmc.ncbi.nlm.nih.gov",
      "host": "pmc.ncbi.nlm.nih.gov"
    },
    {
      "number": 24,
      "title": "Correction Rates and Clinical Outcomes in Hospitalized Adults With Severe Hyponatremia: A Systematic Review and Meta-Analysis. - Abstract",
      "detail": "pubmed.ncbi.nlm.nih.gov",
      "url": "https://pubmed.ncbi.nlm.nih.gov/39556338",
      "authors": "pubmed.ncbi.nlm.nih.gov",
      "host": "pubmed.ncbi.nlm.nih.gov"
    }
  ],
  "editorialNote": "Prepared from cited clinical literature using Astra's research workflow. Verify recommendations against current guidance and patient-specific factors.",
  "citations": [
    {
      "number": 1,
      "title": "These highlights do not include all the information needed to use ...",
      "detail": "dailymed.nlm.nih.gov",
      "url": "https://dailymed.nlm.nih.gov/dailymed/fda/fdaDrugXsl.cfm?setid=e5bbb3e1-ab50-4ec7-a2b4-ce4091712e23&type=display",
      "authors": "dailymed.nlm.nih.gov",
      "host": "dailymed.nlm.nih.gov",
      "snippet": "Rapid correction of hyponatremia is potentially dangerous with risk ... osmotic demyelination syndrome with risk of seizures and cerebral edema. ... risk factors",
      "score": 0.82492816
    },
    {
      "number": 2,
      "title": "[PDF] center for drug evaluation and - accessdata.fda.gov",
      "detail": "www.accessdata.fda.gov",
      "url": "https://www.accessdata.fda.gov/drugsatfda_docs/nda/2009/022275s000_Lbl.pdf",
      "authors": "www.accessdata.fda.gov",
      "host": "www.accessdata.fda.gov",
      "snippet": "Osmotic demyelination syndrome is a risk associated with too rapid correction of hyponatremia. Osmotic demyelination results in dysarthria, mutism, dysphagia,",
      "score": 0.82391036
    },
    {
      "number": 3,
      "title": "[PDF] SAMSCA - DailyMed",
      "detail": "dailymed.nlm.nih.gov",
      "url": "https://dailymed.nlm.nih.gov/dailymed/getFile.cfm?setid=5526617c-c7b9-4556-886d-729bbabbc566&type=pdf",
      "authors": "dailymed.nlm.nih.gov",
      "host": "dailymed.nlm.nih.gov",
      "snippet": "Too rapid correction of hyponatremia (e.g., >12 mEq/L/24 hours) can cause osmotic demyelination resulting in dysarthria, mutism, dysphagia, lethargy, affective changes, spastic quadriparesis, seizures, coma and death. In susceptible patients, including those with severe malnutrition, alcoholism or a",
      "score": 0.8020137
    },
    {
      "number": 4,
      "title": "[PDF] Page 1 of 27 This label may not be the latest approved by FDA. For ...",
      "detail": "www.accessdata.fda.gov",
      "url": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2009/022275lbl.pdf",
      "authors": "www.accessdata.fda.gov",
      "host": "www.accessdata.fda.gov",
      "snippet": "Osmotic demyelination syndrome is a risk associated with too rapid correction of hyponatremia (e.g., >12 mEq/L/24 hours). Osmotic",
      "score": 0.8010817
    },
    {
      "number": 5,
      "title": "[PDF] 3080478 This label may not be the latest approved by FDA. For ...",
      "detail": "www.accessdata.fda.gov",
      "url": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/022275s005lbl.pdf",
      "authors": "www.accessdata.fda.gov",
      "host": "www.accessdata.fda.gov",
      "snippet": "saquinavir, nefazodone, and telithromycin. 4.5 Anuric patients In patients unable to make urine, no clinical benefit can be expected. 5 WARNINGS AND PRECAUTIONS 5.1 Too Rapid Correction of Serum Sodium Can Cause Serious Neurologic Sequelae (see BOXED WARNING) Osmotic demyelination syndrome is a risk",
      "score": 0.78393924
    },
    {
      "number": 6,
      "title": "[PDF] tolvaptan tablet - DailyMed",
      "detail": "dailymed.nlm.nih.gov",
      "url": "https://dailymed.nlm.nih.gov/dailymed/getFile.cfm?setid=c075d517-f4c8-469a-9f51-416ef61c6a83&type=pdf",
      "authors": "dailymed.nlm.nih.gov",
      "host": "dailymed.nlm.nih.gov",
      "snippet": "• Too rapid correction of hyponatremia (e.g., >12 mEq/L/24 hours) can cause osmotic demyelination resulting in dysarthria, mutism, dysphagia, lethargy, affective changes, spastic quadriparesis, seizures, coma and death. In susceptible patients, including those with severe malnutrition, alcoholism or",
      "score": 0.77589405
    },
    {
      "number": 7,
      "title": "[PDF] POTASSIUM CHLORIDE IN DEXTROSE - DailyMed",
      "detail": "dailymed.nlm.nih.gov",
      "url": "https://dailymed.nlm.nih.gov/dailymed/getFile.cfm?setid=e5bbb3e1-ab50-4ec7-a2b4-ce4091712e23&type=pdf",
      "authors": "dailymed.nlm.nih.gov",
      "host": "dailymed.nlm.nih.gov",
      "snippet": "Rapid correction of hyponatremia is potentially dangerous with risk of serious neurologic complications such as osmotic demyelination syndrome with risk of seizures and cerebral edema. To avoid complications, monitor serum sodium and chloride concentrations, fluid status, acid-base balance, and sign",
      "score": 0.7493996
    },
    {
      "number": 8,
      "title": "Correction Rates and Clinical Outcomes in Hospitalized Adults With ...",
      "detail": "jamanetwork.com",
      "url": "https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/2826087",
      "authors": "jamanetwork.com",
      "host": "jamanetwork.com",
      "snippet": "Importance Hyponatremia treatment guidelines recommend limiting the correction of severe hyponatremia during the first 24 hours to prevent",
      "score": 0.5021246
    },
    {
      "number": 9,
      "title": "Risk of Overcorrection in Rapid Intermittent Bolus vs Slow ...",
      "detail": "jamanetwork.com",
      "url": "https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/2772353",
      "authors": "jamanetwork.com",
      "host": "jamanetwork.com",
      "snippet": "Overcorrection is a good laboratory outcome that can be monitored in patients with hyponatremia who are treated with hypertonic saline and a",
      "score": 0.32456765
    },
    {
      "number": 10,
      "title": "Diagnosis and Management of Hyponatremia: A Review",
      "detail": "jamanetwork.com",
      "url": "https://jamanetwork.com/journals/jama/fullarticle/2794358",
      "authors": "jamanetwork.com",
      "host": "jamanetwork.com",
      "snippet": "Diagnosis and Management of Hyponatremia: A Review | Acid Base, Electrolytes, Fluids | JAMA | JAMA Network\n(#skip-to-navigation)",
      "score": 0.3001303
    },
    {
      "number": 11,
      "title": "Hyponatremia | Annals of Internal Medicine - ACP Journals",
      "detail": "www.acpjournals.org",
      "url": "https://www.acpjournals.org/doi/10.7326/AITC201508040",
      "authors": "www.acpjournals.org",
      "host": "www.acpjournals.org",
      "snippet": "Overcorrection of hyponatremia is a medical emergency and should be avoided. If plasma sodium increases too rapidly, desmopressin (synthetic",
      "score": 0.5370662
    },
    {
      "number": 12,
      "title": "In hyponatremia, rapid intermittent bolus vs. slow continuous ...",
      "detail": "www.acpjournals.org",
      "url": "https://www.acpjournals.org/doi/10.7326/ACPJ202103160-033",
      "authors": "www.acpjournals.org",
      "host": "www.acpjournals.org",
      "snippet": "Guidelines suggest bolus hypertonic saline for acute symptomatic hyponatremia and chronic hyponatremia with severe symptoms",
      "score": 0.24124394
    },
    {
      "number": 13,
      "title": "Therapeutic Relowering of Plasma Sodium after... : Clinical Journal of the American Society of Nephrology",
      "detail": "journals.lww.com",
      "url": "https://journals.lww.com/cjasn/fulltext/10.2215/cjn.04880419~therapeutic-relowering-of-plasma-sodium-after-overly-rapid",
      "authors": "journals.lww.com",
      "host": "journals.lww.com",
      "snippet": "Overly rapid correction of hyponatremia is defined as a plasma sodium correction rate exceeding the recommended limits, but controversy still exists about what those limits are. Two common limits used are (_1_) >10–12 mEq/L in the first 24 hours and >18 mEq/L in the first 48 hours; and (_2_) >8 mEq/",
      "score": 0.5634506
    },
    {
      "number": 14,
      "title": "Risk Factors, Complication and Measures to Prevent or Reverse Catastrophic Sodium Overcorrection in Chronic Hyponatremia - ScienceDirect",
      "detail": "www.sciencedirect.com",
      "url": "https://www.sciencedirect.com/science/article/pii/S0002962915301245",
      "authors": "www.sciencedirect.com",
      "host": "www.sciencedirect.com",
      "snippet": "# Review Article Risk Factors, Complication and Measures to Prevent or Reverse Catastrophic Sodium Overcorrection in Chronic Hyponatremia. For these patients, early identification of risk factors, close monitoring of serum sodium correction and the use of 5% dextrose with or without desmopressin to ",
      "score": 0.769306
    },
    {
      "number": 15,
      "title": "Use of the Desmopressin Clamp in Hyponatremia : Kidney360",
      "detail": "journals.lww.com",
      "url": "https://journals.lww.com/kidney360/fulltext/2025/09000/use_of_the_desmopressin_clamp_in_hyponatremia_.2.aspx",
      "authors": "journals.lww.com",
      "host": "journals.lww.com",
      "snippet": "Open\n\nCorresponding Article\n\nCorresponding Article\n\nSince the first report of osmotic demyelination syndrome (ODS) by Adams and Victor in 1959,1 the safest approach to correcting hyponatremia has remained a topic of ongoing debate. Although ODS is most commonly associated with rapid correction of ch",
      "score": 0.67140645
    },
    {
      "number": 16,
      "title": "Outcomes in Severe Hyponatremia Treated With and Without Desmopressin - ScienceDirect",
      "detail": "www.sciencedirect.com",
      "url": "https://www.sciencedirect.com/science/article/abs/pii/S0002934317310434",
      "authors": "www.sciencedirect.com",
      "host": "www.sciencedirect.com",
      "snippet": "Title: Outcomes in Severe Hyponatremia Treated With and Without Desmopressin - ScienceDirect\n# Clinical Research Study Outcomes in Severe Hyponatremia Treated With and Without Desmopressin. Overcorrection of plasma sodium in severe hyponatremia is associated with osmotic demyelination syndrome. Desm",
      "score": 0.65597594
    },
    {
      "number": 17,
      "title": "Osmotic Demyelination Syndrome - ScienceDirect",
      "detail": "www.sciencedirect.com",
      "url": "https://www.sciencedirect.com/science/article/pii/S0002962915315810",
      "authors": "www.sciencedirect.com",
      "host": "www.sciencedirect.com",
      "snippet": "The osmotic demyelination syndrome (ODS) has been a recognized complication of the rapid correction of hyponatremia for decades. Although slow correction of hyponatremia seems to be the best way to prevent development of the syndrome, there are new data that suggest reintroduction of hyponatremia in",
      "score": 0.61972505
    },
    {
      "number": 18,
      "title": "Potomania - an overview | ScienceDirect Topics",
      "detail": "www.sciencedirect.com",
      "url": "https://www.sciencedirect.com/topics/medicine-and-dentistry/potomania",
      "authors": "www.sciencedirect.com",
      "host": "www.sciencedirect.com",
      "snippet": "Beer potomania is a rare cause of severe hyponatremia, and it is associated with a high rate of mortality and the osmotic demyelination syndrome (ODS).82 The diagnosis is made based on the clinical history of heavy alcohol consumption in the setting of an otherwise poor nutritional intake and recogn",
      "score": 0.6052631
    },
    {
      "number": 19,
      "title": "The Resuscitationist’s Approach to Severe Hyponatremia | Critical Care Medicine Section",
      "detail": "www.acep.org",
      "url": "https://www.acep.org/criticalcare/newsroom/newsroom-articles/september2022/the-resuscitationists-approach-to-severe-hyponatremia",
      "authors": "www.acep.org",
      "host": "www.acep.org",
      "snippet": "Remain vigilant against overcorrection in hyponatremic patients who received a fluid bolus and who begin auto-diuresing. The first indication will be dilute urine at the proximal foley and large amounts of urine output, essentially free water, which causes the serum sodium to rise quickly.1 Overcorr",
      "score": 0.4797236
    },
    {
      "number": 20,
      "title": "Effects of Correction Rate for Severe Hyponatremia in the Intensive Care Unit on Patient Outcomes",
      "detail": "pmc.ncbi.nlm.nih.gov",
      "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC10524223",
      "authors": "pmc.ncbi.nlm.nih.gov",
      "host": "pmc.ncbi.nlm.nih.gov",
      "snippet": "The relationship between the correction rates of serum sodium concentration and the incidence of ODS remains unclear. While some studies have suggested that ODS is more common with higher rates of correction, with most cases having a 24-hour correction rate >12 mEq/L [6, 9–12], other studies have fa",
      "score": 0.83742094
    },
    {
      "number": 21,
      "title": "Hyponatremia Correction and Osmotic Demyelination Syndrome Risk: A Systematic Review and Meta-Analysis",
      "detail": "pmc.ncbi.nlm.nih.gov",
      "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC11833618",
      "authors": "pmc.ncbi.nlm.nih.gov",
      "host": "pmc.ncbi.nlm.nih.gov",
      "snippet": "A previous systematic review identified 14 distinct criteria for the overcorrection of hyponatremia, with a median rate ranging from 6.48-27 mmol/L/24 hours.31 However, we found included studies that used criteria defined as rapid correction of≥8 mmol/L within 24 hr. We used 3 cut-off values for sod",
      "score": 0.8215175
    },
    {
      "number": 22,
      "title": "Difficulties in the diagnosis and management of hyponatremia - PMC",
      "detail": "pmc.ncbi.nlm.nih.gov",
      "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC5111484",
      "authors": "pmc.ncbi.nlm.nih.gov",
      "host": "pmc.ncbi.nlm.nih.gov",
      "snippet": "## : at-risk patients have serum Na<120 mEq/l for >48 hours, and high risk if serum Na<105 mEq/l, or with hypokalemia, alcoholism, malnutrition, or advanced cirrhosis. The correction rate should not exceed 4–8 mEq/l per day in low-risk patients with chronic SIADH and 4–6 mEq/l/day in patients at hig",
      "score": 0.78963995
    },
    {
      "number": 23,
      "title": "Treatment Guidelines for Hyponatremia: Stay the Course - PMC",
      "detail": "pmc.ncbi.nlm.nih.gov",
      "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC10843202",
      "authors": "pmc.ncbi.nlm.nih.gov",
      "host": "pmc.ncbi.nlm.nih.gov",
      "snippet": "include sodium ≤105 mmol/L, alcohol use disorder, hypokalemia, malnutrition, or advanced liver disease. In these _high-risk patients_, the US/Irish expert panel recommended that correction should not exceed 8 mmol/L in _any_ 24-hour period and that the minimum daily correction goal should be 4–6 mmo",
      "score": 0.78886026
    },
    {
      "number": 24,
      "title": "Correction Rates and Clinical Outcomes in Hospitalized Adults With Severe Hyponatremia: A Systematic Review and Meta-Analysis. - Abstract",
      "detail": "pubmed.ncbi.nlm.nih.gov",
      "url": "https://pubmed.ncbi.nlm.nih.gov/39556338",
      "authors": "pubmed.ncbi.nlm.nih.gov",
      "host": "pubmed.ncbi.nlm.nih.gov",
      "snippet": "We searched MEDLINE, Embase, the Cochrane Library, LILACS, Web of Science, CINAHL, and international congress proceedings for studies published between January 2013 and October 2023.\n#### Study selection\n\nComparative studies assessing rapid (≥8-10 mEq/L per 24 hours) vs slow (<8 or 6-10 mEq/L per 24",
      "score": 0.6222074
    }
  ],
  "publishedAt": "2026-09-15T21:44:41.994003+00:00",
  "updatedAt": "2026-09-15T21:44:41.994003+00:00",
  "readingMinutes": 7,
  "slug": "hyponatremia-overcorrection-management"
}